Innovation Pharmaceuticals Inc (IPIX)

[Justfactsmam]

AMAZING COMPLAINT!:

"There's no R&D, there's no manufacturing, distribution... nothing. Zero."

1. "There is no R&D - WRONG...read the PR's (RP's for Loan)

...today announced that antiviral research related to Brilacidin has been accepted for an Oral Presentation at the 2021 Military Health System Research Symposium (MHSRS).

https://www.ipharminc.com/press-release/2021/6/18/innovation-pharma-announces-new-brilacidin-antiviral-research-on-non-sars-cov-2-endemic-viral-diseases-to-be-presented-at-the-2021-military-health-system-research-symposium

“Encouraged by extensive laboratory-based Brilacidin antiviral research focused on coronaviruses, and building on previous pre-clinical and clinical results demonstrating a robust Brilacidin therapeutic profile, we prioritized the development of Brilacidin as a novel antiviral. To us, this is much more than a COVID-19 study. Our goal is to develop a broad spectrum antiviral not just to help contain today’s pandemic, but also one that could be deployed against other infectious and deadly viruses that inevitably will follow. As such, we eagerly look forward to our Brilacidin COVID-19 trial readout.”


"...Brilacidin is the only non-peptidic defensin-mimetic drug candidate currently in a clinical trial as a treatment for SARS-CoV-2, the coronavirus responsible for COVID-19. Additionally, Brilacidin has shown potent and consistent inhibition in vitro against coronaviruses, alphaviruses and bunyaviruses (with lab testing against other viruses also underway), supporting Brilacidin’s potential to be developed as a broad spectrum antiviral...."

https://www.ipharminc.com/press-release/2021/6/3/innovation-pharma-completes-enrollment-in-phase-2-clinical-trial-for-covid-19


2. "There's no manufacturing..." Wrong...PR citing the production of pill form for U.C.

...there would not be a call for more Manufacturing beyond supplying clinical trials and research until trial results...

3. "Distribution" ... of a DRUG WITHOUT FDA APPROVAL...why would anyone expect "distribution" until FDA EUA or Approval!..

very poor attempts at Strawman setup...

Almost as bad as refuting or questioning the 60-day hold on data release from completion of study (as per RP...LOL):

"Complete trial enrollment comprised 120 dosed patients recruited across multiple sites. Final data collection for the last patient enrolled in the study is expected to occur in early August (Study Day 60), which will then be followed by the process of unblinding study data and the reporting of topline study results."

https://www.ipharminc.com/press-release/2021/6/3/innovation-pharma-completes-enrollment-in-phase-2-clinical-trial-for-covid-19


"Not a clue what 'GBL' means/is....try "RBL"